[Erythroblastopenia in a child during treatment of a neuroblastoma].
A 4 year-old child being treated for neuroblastoma developed erythroblastopenia. We used specific erythroid lineage markers (hemoglobin and spectrin) and in vitro erythroid colony assays to characterize this hematologic picture and discuss its relationships with the disease and its treatment.
D001853:Bone Marrow / Q000473:pathology; D002478:Cells, Cultured; D004900:Erythroblasts / Q000473:pathology*; D004921:Erythropoietin / Q000097:blood; D005455:Fluorescent Antibody Technique; D006801:Humans; D007223:Infant; D008297:Male; D009447:Neuroblastoma / Q000150:complications / Q000556:secondary / Q000628:therapy*; D013789:Thalassemia / Q000097:blood / Q000150:complications*
D004921:Erythropoietin
Erythroblastopénie de l'enfant au cours du traitement d'un neuroblastome.